SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. L. Hyrich, S. M. M. Verstappen, Biologic therapies and pregnancy: the story so far, Rheumatology, 2014, 53, 8, 1377

    CrossRef

  2. 2
    Hagit Matz, Biologics in the Treatment of Skin Diseases During Pregnancy and Lactation, Current Dermatology Reports, 2014, 3, 3, 144

    CrossRef

  3. 3
    M. Seirafi, B. Vroey, A. Amiot, P. Seksik, X. Roblin, M. Allez, L. Peyrin-Biroulet, P. Marteau, G. Cadiot, D. Laharie, A. Boureille, M. De Vos, G. Savoye, J.-F. Rahier, F. Carbonnel, B. Bonaz, J.-F. Colombel, Y. Bouhnik, Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 4
  4. 4
    F. Magro, C. Abreu, Immunisations in Crohn's disease: Who? Why? What? When?, Best Practice & Research Clinical Gastroenterology, 2014, 28, 3, 485

    CrossRef

  5. 5
    Martin Bortlik, Dana Duricova, Nadezda Machkova, Jana Kozeluhova, Pavel Kohout, Ludek Hrdlicka, Marianna Durilova, Katarina Mitrova, Ondrej Hradsky, Jiri Bronsky, Karin Malickova, Milan Lukas, Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children, Inflammatory Bowel Diseases, 2014, 20, 3, 495

    CrossRef

  6. 6
    Qiaoling Du, Youhua Zhang, Youdong Pan, Tao Duan, Lithocholic acid-induced placental tumor necrosis factor-α upregulation and syncytiotrophoblast cell apoptosis in intrahepatic cholestasis of pregnancy, Hepatology Research, 2014, 44, 5
  7. 7
    Susie W. Ng, Uma Mahadevan, My Treatment Approach to Management of the Pregnant Patient With Inflammatory Bowel Disease, Mayo Clinic Proceedings, 2014, 89, 3, 355

    CrossRef

  8. 8
    Jeff Chang, Rupert WL Leong, Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure, Expert Opinion on Biological Therapy, 2014, 14, 1, 27

    CrossRef

  9. 9
    Orna Diav-Citrin, Anna Otcheretianski-Volodarsky, Svetlana Shechtman, Asher Ornoy, Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study, Reproductive Toxicology, 2014, 43, 78

    CrossRef

  10. 10
    Sara Horst, Sunanda Kane, The Use of Biologic Agents in Pregnancy and Breastfeeding, Gastroenterology Clinics of North America, 2014,

    CrossRef

  11. 11
    Sarah Sheibani, Uma Mahadevan, Editorial: Are Thiopurines and Anti-TNFα Agents Safe to Use in Pregnant Patients With Inflammatory Bowel Disease?, The American Journal of Gastroenterology, 2013, 108, 3, 441

    CrossRef

  12. 12
    Zuzana Zelinkova, Cokkie van der Ent, Karlien F. Bruin, Onno van Baalen, Hestia G. Vermeulen, Herman J.T. Smalbraak, Rob J. Ouwendijk, Aad C. Hoek, Sjoerd D. van der Werf, Ernst J. Kuipers, C. Janneke van der Woude, Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure, Clinical Gastroenterology and Hepatology, 2013, 11, 3, 318

    CrossRef

  13. 13
    Petru Cristian Simon, Antonio Vallano, Fármacos que inhiben el factor de necrosis tumoral α y embarazo, Medicina Clínica, 2013, 141, 6, 257

    CrossRef

  14. 14
    Míriam Mañosa, Mercè Navarro-Llavat, Laura Marín, Yamile Zabana, Eduard Cabré, Eugeni Domènech, Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey, Scandinavian Journal of Gastroenterology, 2013, 48, 4, 427

    CrossRef

  15. 15
    Ole Haagen Nielsen, Cynthia Maxwell, Jakob Hendel, IBD medications during pregnancy and lactation, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 2, 116

    CrossRef

  16. 16
    Uma Mahadevan, Douglas C. Wolf, Marla Dubinsky, Antoine Cortot, Scott D. Lee, Corey A. Siegel, Thomas Ullman, Sarah Glover, John F. Valentine, David T. Rubin, Jocelyn Miller, Maria T. Abreu, Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, 2013, 11, 3, 286

    CrossRef

  17. 17
    Martin Bortlik, Nadezda Machkova, Dana Duricova, Karin Malickova, Ludek Hrdlicka, Martin Lukas, Pavel Kohout, Olga Shonova, Milan Lukas, Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study, Scandinavian Journal of Gastroenterology, 2013, 48, 8, 951

    CrossRef

  18. 18
    Javier P Gisbert, María Chaparro, Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2013, 108, 9, 1426

    CrossRef

  19. 19
    M J Casanova, M Chaparro, E Domènech, M Barreiro-de Acosta, F Bermejo, E Iglesias, F Gomollón, L Rodrigo, X Calvet, M Esteve, E García-Planella, S García-López, C Taxonera, M Calvo, M López, D Ginard, M Gómez-García, E Garrido, J L Pérez-Calle, B Beltrán, M Piqueras, C Saro, B Botella, C Dueñas, A Ponferrada, M Mañosa, V García-Sánchez, J Maté, J P Gisbert, Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2013, 108, 3, 433

    CrossRef

  20. 20
    N. Pedersen, A. Bortoli, D. Duricova, R. D′Inca, M. R. Panelli, J. P. Gisbert, G. Zoli, A. López-Sanromán, F. Castiglione, G. Riegler, V. Annese, P. Gionchetti, A. Prada, E. D. Pont, A. Timmer, C. Felley, M. Shuhaibar, E. V. Tsianos, C. Dejaco, F. J. Baert, T. Jess, M. Lebech, D. W. Hommes, P. Munkholm, The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women, Alimentary Pharmacology & Therapeutics, 2013, 38, 5
  21. 21
    Andres Yarur, Sunanda V. Kane, Update on pregnancy and breastfeeding in the era of biologics, Digestive and Liver Disease, 2013, 45, 10, 787

    CrossRef

  22. You have free access to this content22
    Charlotte I. de Bie, Johanna C. Escher, Lissy de Ridder, Antitumor necrosis factor treatment for pediatric inflammatory bowel disease, Inflammatory Bowel Diseases, 2012, 18, 5
  23. 23
    Christina D. Chambers, Diana L. Johnson, Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 8
  24. 24
    Isabella Ellinger, Renate Fuchs, HFcRn-mediated transplacental immunoglobulin G transport: Protection of and threat to the human fetus and newborn, Wiener Medizinische Wochenschrift, 2012, 162, 9-10, 207

    CrossRef

  25. 25
    Ole Haagen Nielsen, Tine Jess, IBD: Can TNF inhibitors be administered during the third trimester?, Nature Reviews Gastroenterology & Hepatology, 2012, 10, 3, 130

    CrossRef

  26. 26
    Oier Ateka-Barrutia, Catherine Nelson-Piercy, Management of rheumatologic diseases in pregnancy, International Journal of Clinical Rheumatology, 2012, 7, 5, 541

    CrossRef

  27. 27
    Luc Biedermann, Gerhard Rogler, Stephan R. Vavricka, Frank Seibold, Mariam Seirafi, Pregnancy and Breastfeeding in Inflammatory Bowel Disease, Digestion, 2012, 86, s1, 45

    CrossRef

  28. 28
    Walter Reinisch, Gert Van Assche, Ragnar Befrits, William Connell, Geert D'Haens, Subrata Ghosh, Pierre Michetti, Thomas Ochsenkühn, Remo Panaccione, Stefan Schreiber, Mark S. Silverberg, Dario Sorrentino, C. Janneke van der Woude, Séverine Vermeire, Julian Panes, Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus, Journal of Crohn's and Colitis, 2012, 6, 2, 248

    CrossRef

  29. You have free access to this content29
    F. M. Habal, V. W. Huang, Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient, Alimentary Pharmacology & Therapeutics, 2012, 35, 5
  30. 30
    A.S. Bansal, B. Bajardeen, M.Y. Thum, The basis and value of currently used immunomodulatory therapies in recurrent miscarriage, Journal of Reproductive Immunology, 2012, 93, 1, 41

    CrossRef

  31. 31
    Casper Steenholdt, Magid Al-Khalaf, Mark A. Ainsworth, Jørn Brynskov, Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31, Journal of Crohn's and Colitis, 2012, 6, 3, 358

    CrossRef

  32. 32
    May Ching Soh, Catherine Nelson-Piercy, Update of the management of rheumatoid arthritis in pregnancy, Expert Review of Obstetrics & Gynecology, 2012, 7, 1, 77

    CrossRef

  33. 33
    A. Gouraud, T. Vial, Médicaments et Grossesse : Prescrire et évaluer le Risque, 2012,

    CrossRef

  34. 34
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  35. 35
    Sara F Rinaldi, James L Hutchinson, Adriano G Rossi, Jane E Norman, Anti-inflammatory mediators as physiological and pharmacological regulators of parturition, Expert Review of Clinical Immunology, 2011, 7, 5, 675

    CrossRef

  36. 36
    Conor Lahiff, Alan C. Moss, Cyclosporine in the management of severe ulcerative colitis while breast-feeding, Inflammatory Bowel Diseases, 2011, 17, 7
  37. 37
    Nada Djokanovic, Chagit Klieger-Grossmann, Anna Pupco, Gideon Koren, Safety of infliximab use during pregnancy, Reproductive Toxicology, 2011, 32, 1, 93

    CrossRef

  38. 38
    J. Walldorf, M.M. Dollinger, T. Seufferlein, Schwangerschaft unter Immunsuppression, Der Internist, 2011, 52, 10, 1178

    CrossRef

  39. 39
    Priyadarshini Koduri, Cuckoo Choudhary, Maternal-Fetal Evidence Based Guidelines, 2011,

    CrossRef